157 related articles for article (PubMed ID: 35380381)
1. A Case of Neonatal Severe Hyperparathyroidism: Challenges in Management.
Gupta P; Tak SA; S AV; Misgar RA; Agarwala S; Jain V; Sharma R
Indian J Pediatr; 2022 Oct; 89(10):1025-1027. PubMed ID: 35380381
[TBL] [Abstract][Full Text] [Related]
2. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
[TBL] [Abstract][Full Text] [Related]
3. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
[TBL] [Abstract][Full Text] [Related]
4. Unusual case of neonatal hypercalcemia.
Brickman TM; Stark MW; Jeyakumar A
Int J Pediatr Otorhinolaryngol; 2015 May; 79(5):758-9. PubMed ID: 25792032
[TBL] [Abstract][Full Text] [Related]
5. Neonatal severe hyperparathyroidism: further clinical and molecular delineation.
Al-Khalaf FA; Ismail A; Soliman AT; Cole DE; Ben-Omran T
Eur J Pediatr; 2011 May; 170(5):625-31. PubMed ID: 20972686
[TBL] [Abstract][Full Text] [Related]
6. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
Marx SJ; Sinaii N
J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
[TBL] [Abstract][Full Text] [Related]
8. The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
Özgüç Çömlek F; Demir S; Gürkan H; İnan M; Sezer A; Dilek E; Kökenli F
Pediatr Endocrinol Diabetes Metab; 2022; 28(2):168-174. PubMed ID: 35399047
[TBL] [Abstract][Full Text] [Related]
9. Neonatal hypercalcemia due to a homozygous mutation in the calcium-sensing receptor: failure of cinacalcet.
García Soblechero E; Ferrer Castillo MT; Jiménez Crespo B; Domínguez Quintero ML; González Fuentes C
Neonatology; 2013; 104(2):104-8. PubMed ID: 23817301
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
[TBL] [Abstract][Full Text] [Related]
11. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
Atay Z; Bereket A; Haliloglu B; Abali S; Ozdogan T; Altuncu E; Canaff L; Vilaça T; Wong BY; Cole DE; Hendy GN; Turan S
Bone; 2014 Jul; 64():102-7. PubMed ID: 24735972
[TBL] [Abstract][Full Text] [Related]
12. Successful use of cinacalcet monotherapy in the management of siblings with homozygous calcium-sensing receptor mutation.
Wade L; Aindow A; Isherwood L; Mughal MZ; Ramakrishnan R
J Pediatr Endocrinol Metab; 2022 Apr; 35(4):549-556. PubMed ID: 35073615
[TBL] [Abstract][Full Text] [Related]
13. Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.
Sun X; Huang L; Wu J; Tao Y; Yang F
Medicine (Baltimore); 2018 Nov; 97(45):e13128. PubMed ID: 30407334
[TBL] [Abstract][Full Text] [Related]
14. Challenges in diagnosis and management of neonatal hyperparathyroidism in a resource-limited country: a case series from a Sudanese family.
Hassan SS; Kempers M; Lugtenberg D; Abdallah AT; Musa SA; Ibrahim AA; Abdullah MA
Pan Afr Med J; 2021; 40():105. PubMed ID: 34887979
[TBL] [Abstract][Full Text] [Related]
15. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
[TBL] [Abstract][Full Text] [Related]
16. Neonatal severe hyperparathyroidism due to compound heterozygous mutation of calcium sensing receptor (CaSR) gene presenting as encephalopathy.
Kulkarni A; Mohite M; Vijaykumar R; Bansode P; Murade S; Tamhankar PM
Indian J Pediatr; 2014 Nov; 81(11):1228-9. PubMed ID: 24763815
[TBL] [Abstract][Full Text] [Related]
17. Neonatal severe hyperparathyroidism due to a homozygous mutation of calcium-sensing receptor; a challenging case.
Hashim R; Levine MA; Somasundarum K; Lamahewage A; Atapattu N
Ceylon Med J; 2019 Dec; 64(4):155-157. PubMed ID: 32120468
[No Abstract] [Full Text] [Related]
18. Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
Panova AV; Kulikova KS; Klementieva NV; Krylov ID; Snezhko IO; Tiulpakov AN; Kiselev SL
Stem Cell Res; 2021 Jul; 54():102414. PubMed ID: 34111698
[TBL] [Abstract][Full Text] [Related]
19. Case Report: Severe Neonatal Course in Paternally Derived Familial Hypocalciuric Hypercalcemia.
Höppner J; Lais S; Roll C; Wegener-Panzer A; Wieczorek D; Högler W; Grasemann C
Front Endocrinol (Lausanne); 2021; 12():700612. PubMed ID: 34659108
[TBL] [Abstract][Full Text] [Related]
20. Primary hyperparathyroidism in children and adolescents.
Roizen J; Levine MA
J Chin Med Assoc; 2012 Sep; 75(9):425-34. PubMed ID: 22989537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
